- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 92,710 | 09.07.24 08:20:01 | +0,200 | +0,22% | 92,520 | 92,950 | 92,710 | 92,510 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 970,200 | 09.07.24 08:03:31 | +10,000 | +1,04% | 966,600 | 978,200 | 970,200 | 960,200 |
